Literature DB >> 20708905

Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression.

Siegfried Kasper1, Filippo Caraci, Bruno Forti, Filippo Drago, Eugenio Aguglia.   

Abstract

Depression is a common condition in the community with a significant impact on affected individuals, their relatives and society. Many patients with depression do not seek treatment and are often concerned about the possible adverse effects of antidepressant drugs. Extract of Hypericum perforatum (St. John's wort) has long been recognized as a treatment for depression. Several published trials and meta-analyses have demonstrated the efficacy and tolerability of Hypericum extract for mild to moderate depression. Recent comparative trials of Hypericum extract and other antidepressants, including selective serotonin reuptake inhibitors (SSRIs), provide support for Hypericum extract efficacy. However, since the constituents of Hypericum extract differ between the individual manufacturers, the efficacy cannot be extrapolated from one extract to another. In this review, WS 5572, LI 160, WS 5570 and ZE 117 Hypericum extracts have been shown to be significantly more effective than placebo with at least similar efficacy and better tolerability compared to standard antidepressant drugs.
Copyright © 2010 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20708905     DOI: 10.1016/j.euroneuro.2010.07.005

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  17 in total

1.  A Case of Panic Attack Induced by St John's Wort.

Authors:  Osman Yildirim; Fatih Canan
Journal:  Prim Care Companion CNS Disord       Date:  2013

2.  Phytomedicines in the Treatment of Migraine.

Authors:  Thilinie Rajapakse; William Jeptha Davenport
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

3.  Reversal of NO-induced nociceptive hypersensitivity by St. John's wort and hypericin: NF-κB, CREB and STAT1 as molecular targets.

Authors:  Nicoletta Galeotti; Carla Ghelardini
Journal:  Psychopharmacology (Berl)       Date:  2012-12-20       Impact factor: 4.530

4.  Early effect of NEURAPAS® balance on current source density (CSD) of human EEG.

Authors:  Wilfried Dimpfel; Klaus Koch; Gabriele Weiss
Journal:  BMC Psychiatry       Date:  2011-08-02       Impact factor: 3.630

5.  St. John's wort extract and hyperforin protect rat and human pancreatic islets against cytokine toxicity.

Authors:  Michela Novelli; Pascale Beffy; Marta Menegazzi; Vincenzo De Tata; Luisa Martino; Anna Sgarbossa; Svetlana Porozov; Anna Pippa; Matilde Masini; Piero Marchetti; Pellegrino Masiello
Journal:  Acta Diabetol       Date:  2014-02       Impact factor: 4.280

6.  Depression, Comorbidities, and Prescriptions of Antidepressants in a German Network of GPs and Specialists with Subspecialisation in Anthroposophic Medicine: A Longitudinal Observational Study.

Authors:  Elke Jeschke; Thomas Ostermann; Horst C Vollmar; Manuela Tabali; Harald Matthes
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-06       Impact factor: 2.629

7.  Population Variability of Main Secondary Metabolites in Hypericum lydium Boiss. (Hypericaceae).

Authors:  Cüneyt Çirak; Jolita Radusiene; Liudas Ivanauskas; Valdas Jakstas; Necdet Çamaş
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

Review 8.  Roles of chemical complexity and evolutionary theory in some hepatic and intestinal enzymatic systems in chemical reproducibility and clinical efficiency of herbal derivatives.

Authors:  Francesco Di Pierro
Journal:  ScientificWorldJournal       Date:  2014-04-06

Review 9.  Overview of Botanical Status in EU, USA, and Thailand.

Authors:  Weena Jiratchariyakul; Gail B Mahady
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-21       Impact factor: 2.629

Review 10.  Hypericin in the Light and in the Dark: Two Sides of the Same Coin.

Authors:  Zuzana Jendželovská; Rastislav Jendželovský; Barbora Kuchárová; Peter Fedoročko
Journal:  Front Plant Sci       Date:  2016-05-06       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.